Cargando…
Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
In the ongoing coronavirus disease 2019 (COVID-19) pandemic, there remain unanswered questions regarding the nature and significance of the humoral immune response toward other coronavirus infections. Here, we investigate the cross-reactivity of antibodies raised against the first severe acute respi...
Autores principales: | Bates, Timothy A., Weinstein, Jules B., Farley, Scotland, Leier, Hans C., Messer, William B., Tafesse, Fikadu G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s).
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835103/ https://www.ncbi.nlm.nih.gov/pubmed/33545052 http://dx.doi.org/10.1016/j.celrep.2021.108737 |
Ejemplares similares
-
Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2020) -
A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
por: Weinstein, Jules B., et al.
Publicado: (2022) -
A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants
por: Farley, Scotland E., et al.
Publicado: (2022) -
The time between vaccination and infection impacts immunity against SARS-CoV-2 variants
por: Bates, Timothy A., et al.
Publicado: (2023) -
Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serum
por: Bates, Timothy A., et al.
Publicado: (2021)